Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
In June we wrapped up our 2024 conference season, aligning with the academic calendar. Altogether...
Last year we launched a new 2-day format for conferences on emerging topics, which were met with...
By Shannon Weiman
As climate change increasingly impacts society and human health around the globe,...
AI and Machine learning are transforming biomedical research at an astounding pace, enabling...
We are pleased to announce the launch of a new 2-day conference format for conferences on emerging...
As we wrap up our fall season, the community has taken to Twitter/X with rave reviews and...
Keystone Symposia conferences hold a special place in science for their ability to drive...
Over the course of the last 50 years, Keystone Symposia has convened conferences that connect...
